Contingent Valuation: A Pilot Study for Eliciting Willingness to Pay for a Reduction in Mortality From Vaccine-Preventable Illnesses for Children and Adults in Bangladesh
- PMID: 33508753
- PMCID: PMC8163603
- DOI: 10.1016/j.vhri.2020.10.004
Contingent Valuation: A Pilot Study for Eliciting Willingness to Pay for a Reduction in Mortality From Vaccine-Preventable Illnesses for Children and Adults in Bangladesh
Abstract
Objectives: The contingent valuation (CV) method elicits willingness to pay (WTP) for calculating the value of statistical life (VSL). CV approaches for assessing VSL are uncommon in many low and middle-income countries (LMICs). Between 2008 and 2018 only 44 articles utilized WTP in a health-related field and of these only 5 (11%) utilized CV to assess the WTP for a mortality risk reduction. We elicit WTP estimates and compute VSL using the CV method in Bangladesh.
Methods: The pilot study was primarily aimed at developing best practice guidelines for CV studies in LMICs to get more robust WTP estimates. To this end, we explored three methodological a) Varying the name of the intervention, keeping all other characteristics constant; b) varying the effectiveness of the health intervention and c) offering an overnight period to think about the WTP scenario. The survey was administered 413 randomly selected participants. VSL was for a 1/3000 mortality risk reduction.
Results: We had more males (54%) than females (46%) and the mean annual self-reported income was $5,683.36. Mean VSL is $11,339.70 with a median of $10,413. The ratio of child: adult WTP is approximately 1 by both gender and age category. The vaccine intervention had the largest amount of $0 WTP and protest responses (52% and 58% respectively). 93% of the participants were able to describe (teach-back) the vaccine effectiveness using their own family as an example.
Conclusion: Our study provides empirical evidence on how to better generate CV surveys to produce more robust WTP estimates.
Keywords: Bangladesh; contingent valuation; dengue; economic burden; stated preference methods; vaccine-preventable diseases; value of statistical life (VSL).
Copyright © 2020. Published by Elsevier Inc.
Figures
Similar articles
-
Hypothetical assessment of efficiency, willingness-to-accept and willingness-to-pay for dengue vaccine and treatment: a contingent valuation survey in Bangladesh.Hum Vaccin Immunother. 2021 Mar 4;17(3):773-784. doi: 10.1080/21645515.2020.1796424. Epub 2020 Aug 21. Hum Vaccin Immunother. 2021. PMID: 32820987 Free PMC article.
-
The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study.Cost Eff Resour Alloc. 2018 Nov 22;16:60. doi: 10.1186/s12962-018-0163-2. eCollection 2018. Cost Eff Resour Alloc. 2018. PMID: 30479577 Free PMC article.
-
Consumer Perception of Food Safety and Valuation of Statistical Life: A Contingent Valuation Study.Foods. 2024 Aug 20;13(16):2597. doi: 10.3390/foods13162597. Foods. 2024. PMID: 39200524 Free PMC article.
-
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies.Eur J Health Econ. 2022 Dec;23(9):1455-1482. doi: 10.1007/s10198-022-01437-x. Epub 2022 Feb 15. Eur J Health Econ. 2022. PMID: 35166973 Free PMC article.
-
Willingness to pay for diagnostic technologies: a review of the contingent valuation literature.Value Health. 2013 Jul-Aug;16(5):797-805. doi: 10.1016/j.jval.2013.04.005. Epub 2013 Jun 14. Value Health. 2013. PMID: 23947973 Review.
Cited by
-
Value of statistical life year in extreme poverty: a randomized experiment of measurement methods in rural Burkina Faso.Popul Health Metr. 2021 Nov 17;19(1):45. doi: 10.1186/s12963-021-00275-y. Popul Health Metr. 2021. PMID: 34789286 Free PMC article.
-
Estimating the cost of and willingness to pay for providing the dapivirine ring for HIV prevention in Kenya.BMC Public Health. 2025 Mar 22;25(1):1095. doi: 10.1186/s12889-025-22291-5. BMC Public Health. 2025. PMID: 40119338 Free PMC article.
-
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China.Appl Health Econ Health Policy. 2022 May;20(3):417-429. doi: 10.1007/s40258-021-00706-9. Epub 2022 Jan 10. Appl Health Econ Health Policy. 2022. PMID: 35001293 Free PMC article.
-
Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19.BMC Public Health. 2022 Sep 22;22(1):1792. doi: 10.1186/s12889-022-14148-y. BMC Public Health. 2022. PMID: 36131266 Free PMC article.
References
-
- Ozawa S., Clark S., Portnoy A., Grewal S., Brenzel L., Walker D.G. Return on investment from childhood immunization in low- and middle-income countries, 2011-20. Health Aff. 2016;35(2):199–207. - PubMed
-
- Bloom D.E., Brenzel L., Cadarette D., Sullivan J. Moving beyond traditional valuation of vaccination: needs and opportunities. Vaccine. 2017;35(Suppl 1):A29–A35. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical